SP
DXCM icon

SWS Partners’s DexCom DXCM Stock Holding History

SWS Partners’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.9M Sell
43,005
-14,658
-25% -$977K 0.63% 58
2026
Q1 		$3.62M Buy
57,663
+2,103
+4% +$146K 0.89% 33
2025
Q4 		$3.69M Buy
55,560
+17,458
+46% +$1.13M 0.89% 34
2025
Q3 		$2.56M Buy
38,102
+19,073
+100% +$1.51M 0.63% 59
2025
Q2 		$1.66M Buy
+19,029
New +$1.49M 0.45% 79

Other funds holding DXCM

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
DCP
DSM Capital Partners Palm Beach Gardens, Florida $5.84B AUM 22.63% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
FFM
Fisher Funds Management Auckland, New Zealand $3.52B AUM 17.59% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

SWS Partners's DXCM Position: Q2 2026 in Review

SWS Partners reduced its DexCom (DXCM) stake by 25% in Q2 2026, selling an estimated $977K and leaving 43,005 shares worth $2.9M. The position accounts for 0.63% of the portfolio, ranked #58.

SWS Partners first reported a position in DXCM in Q2 2025 and has held it in 5 quarters since. The position peaked at $3.69M in Q4 2025. 427 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • SWS Partners held 43,005 shares of DexCom worth $2.9M as of Q2 2026.
  • SWS Partners sold 14,658 DexCom shares in Q2 2026, an estimated $977K.
  • DexCom made up 0.63% of SWS Partners's portfolio in Q2 2026, its #58 holding.
  • SWS Partners first reported a position in DexCom in Q2 2025 and has held it in 5 quarters since.
  • SWS Partners's DexCom position peaked at $3.69M in Q4 2025.
  • 427 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on SWS Partners's 13F filing for Q2 2026, filed 3 Aug 2026.